Reply to El Bèze et al. and to Tung and Crowley
- PMID: 31247149
- PMCID: PMC6888646
- DOI: 10.1164/rccm.201906-1214LE
Reply to El Bèze et al. and to Tung and Crowley
Comment on
-
Early Use of Norepinephrine in Septic Shock Resuscitation (CENSER). A Randomized Trial.Am J Respir Crit Care Med. 2019 May 1;199(9):1097-1105. doi: 10.1164/rccm.201806-1034OC. Am J Respir Crit Care Med. 2019. PMID: 30704260 Clinical Trial.
-
Early Use of Norepinephrine for Sepsis: Promising Results That Require Confirmation.Am J Respir Crit Care Med. 2019 Nov 1;200(9):1191-1192. doi: 10.1164/rccm.201905-1007LE. Am J Respir Crit Care Med. 2019. PMID: 31247142 Free PMC article. No abstract available.
References
-
- Permpikul C, Tongyoo S, Viarasilpa T, Trainarongsakul T, Chakorn T, Udompanturak S. Early Use of Norepinephrine in Septic Shock Resuscitation (CENSER): a randomized trial. Am J Respir Crit Care Med. 2019;199:1097–1105. - PubMed
-
- Rivers E, Nguyen B, Havstad S, Ressler J, Muzzin A, Knoblich B, et al. Early Goal-Directed Therapy Collaborative Group. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med. 2001;345:1368–1377. - PubMed
-
- Asfar P, Meziani F, Hamel JF, Grelon F, Megarbane B, Anguel N, et al. SEPSISPAM Investigators. High versus low blood-pressure target in patients with septic shock. N Engl J Med. 2014;370:1583–1593. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
